Skip to content

The Assessment of Movement Disorders Utilizing Live Two-Way Video

The Assessment of Movement Disorders Utilizing Live Two-Way Video

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01467089
Enrollment
37
Registered
2011-11-08
Start date
2011-11-30
Completion date
2016-06-30
Last updated
2016-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tardive Dyskinesia

Keywords

Schizophrenia, Extrapyramidal symptoms, Tardive dyskinesia, Two Way Video Assessment

Brief summary

The purpose of this project is to determine the equivalency of extrapyramidal symptoms (EPS) and tardive dyskinesia (TD) examinations conducted via live two-way video versus live examinations completed in-person

Detailed description

Extrapyramidal symptoms (EPS) and tardive dyskinesia (TD) are one of the most frequent and troublesome adverse events when taking antipsychotic agents. The investigators aim in this study to determine if the investigators can conduct examinations for EPS and TD remotely using live two-way video. It is potentially beneficial for patients, especially those who are located far away from psychiatrists if they could be seen by trained clinicians and assessed for EPS and TD via two-way video in the future. Participants will be asked to have a medical assessment which consists of simple questions and some examination of their movements via two-way video and in person. The investigators will compare the results of video examinations with the results of live examinations.

Interventions

OTHERTwo way video assessment

Participants will be assessed extrapyramidal symptoms and tardive dyskinesia

Sponsors

Northwell Health
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Inpatients and outpatients aged 18-75 years old who have been taking antipsychotics for longer than 6 months in their life time, and * That have been compliant for the past week.

Exclusion criteria

* Patients who have medical conditions which make it difficult to perform a physical examination. * Patients who are clinically too ill to consent and/or unable to cooperate with the examination procedures.

Design outcomes

Primary

MeasureTime frame
Abnormal Involuntary Movement Scale (AIMS) when done in-person versus via two-way videoBaseline
Modified Simpson Angus Scale (mSAS) short version when done in-person versus via two-way videoBaseline

Secondary

MeasureTime frameDescription
the correlation between the short version and full version of the Modified Simpson Angus Scale (mSAS)Baselinetotal score of short version-Modified Simpson Angus Scale vs. total score of full version-Modified Simpson Angus Scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026